Need a specific person's email?
Browse Monopar Therapeutics Inc.'s employee directory (about 28 employees) and reveal verified emails free.
Monopar Therapeutics Inc.'s most common email format is Last@monopartx.com (ex. Doe@monopartx.com), used for 88% of monopartx.com addresses. Monopar Therapeutics Inc. uses 3 email patterns.
| Format | Example | Share of monopartx.com |
|---|---|---|
| Last@monopartx.comMost common | Doe@monopartx.com | |
| First@monopartx.com | John@monopartx.com | |
| FirstL@monopartx.com | JohnD@monopartx.com |
Browse Monopar Therapeutics Inc.'s employee directory (about 28 employees) and reveal verified emails free.
Biotechnology ResearchIllinois, United States11-50 Employees
Monopar Therapeutics Inc. is a clinical-stage biotechnology company based in Wilmette, Illinois, focused on treatments for Wilson disease and cancer. Its lead program ALXN1840 targets Wilson disease, while a radiopharmaceutical portfolio addresses advanced cancers, with MNPR-101-Zr and MNPR-101-Lu in Phase 1 trials and MNPR-101-Ac225 in late preclinical development. The company operates within the biotechnology research sector, pursuing therapies for unmet medical needs through its clinical and radiopharmaceutical programs. Based in Wilmette, Illinois, Monopar maintains a relatively small workforce. During 2026, the company presented Phase 2 ALXN1840 data at EASL 2026, reporting liver disease stabilization and neurologic improvement in treatment-experienced Wilson disease patients.
Most common format
Last@monopartx.com
Example: Doe@monopartx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.